Global Acute Respiratory Distress Syndrome Market Size To Exceed USD 2137.6 Billion By 2030 | CAGR of 7.9% New York, United States , April 03, 2023 (GLOBE NEWSWIRE) -- The Global Acute Respiratory Distress Syndrome Market Size to grow from USD 980.4 million in 2021 to USD 2,137.6 million by 2030, at a...

Arch Biopartners Receives Independent Institutional Review Board Approval for Phase II Trial for LSALT Peptide TORONTO, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that it received independent Institutional Review...

Arch Biopartners Submits Application to Health Canada to Conduct COVID19 Phase II Human Trial for Metablok to Prevent Lung and Kidney Inflammation TORONTO, April 23, 2020 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) a clinical stage company developing new drug candidates for treating...